Radionuclide therapy of bone metastases

Piotr Lass

eISSN: 1897-4309
ISSN: 1428-2526

Contemporary Oncology/Współczesna Onkologia

Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

5/2001
vol. 5

Send email

Copy url:

abstract:

Radionuclide therapy of bone metastases

Piotr Lass

Współcz Onkol (2001) vol. 5, 5 (185-187)

Online publish date: 2003/07/18

View full text Get citation

Most patients with bone metastases experience painful symptoms. Systemic radioisotope therapy is an alternative to traditional hemibody radiation in cases of multiple, diffuse metastases. Usually given as a single i.v. slow-push infusion it gives a pain relief beginning after one to three weeks, with a mean duration up to several months, depending of the kind of a radioisotope applied. This paper reviews the role of unsealed source therapy with these bone-seeking radiopharmaceuticals in palliating pain and improving quality of life. Indications, contraindications and complications of this therapy, as well as cost-benefit aspects are discussed.

keywords:

Radionuclide therapy of bone metastases

Piotr Lass

radionuclide therapy, bone metastases